CDK4 and neoplasm: For example, Palbociclib [57, 58] can halt tumor cell proliferation by inhibiting the G1/S phase transition of the cell cycle, while Ribociclib inhibitors prevent the binding of CDK4/6 to D-type cyclin, thereby blocking the G1/S phase transition [59–61].